BCU-FTS-57591 Blood Transfusion Managed Service

Cyfeirnod caffael

BCU-FTS-57591

Disgrifiad caffael

Betsi Cadwaladr University Health Board (BCUHB) Pathology are seeking to appoint an experienced primary Managed Service Contract provider to deliver bespoke In Vitro Diagnostics support for Transfusion services.

BCUHB delivers Transfusion services for Group and Antibody screens, Cross matching, and issuing of products (via remote and electronic

issue) across all 3 acute sites (Ysbyty Wrexham Maelor, Ysbyty Glan Clwyd and Ysbyty Gwynedd), with blood stocks provided on a

remote/electronic issue basis to satellite services in Abergele, Denbigh, and Llandudno hospitals. The service is registered as compliant

with MHRA, and shares a single unified UKAS accreditation across all 3 locations. Each acute site has a fully capable Transfusion

laboratory area as part of the Blood Science laboratory and operates on a 24/7 basis as an established and resilient service model. Each site

also supports theatres, cancer centres and renal units with the relevant specialist requirements.

Prif gategori

Gwasanaethau

Rhanbarthau cyflawni

• UKL23 - Flintshire and Wrexham
• UKL13 - Conwy and Denbighshire
• UKL12 - Gwynedd

Dyddiadau contract (amcangyfrif)

01 Ebrill 2028, 00:00yb to 31 Mawrth 2036, 23:59yh

Dyddiad gorffen yr estyniad (os defnyddir yr holl estyniadau): 31 Mawrth 2043

Betsi Cadwaladr University Health Board

A yw cyfanswm y gwerth uwchlaw'r trothwy?

Uwchben y trothwy

Dosbarthiadau CPV

• 85111800 - Gwasanaethau patholeg
• 85111810 - Gwasanaethau dadansoddi gwaed
• 71900000 - Gwasanaethau labordy

Rhanbarthau cyflawni

• UKL23 - Flintshire and Wrexham
• UKL13 - Conwy and Denbighshire
• UKL12 - Gwynedd

Dyddiad cychwyn y contract (amcangyfrif)

01 Ebrill 2028, 00:00yb

Dyddiad diwedd y contract (amcangyfrif)

31 Mawrth 2036, 23:59yh

Dyddiad gorffen yr estyniad (amcangyfrif)

31 Mawrth 2043, 23:59yh

A ellir ymestyn y contract?

Oes

Dyddiad cyhoeddi hysbysiad tendro (amcangyfrif)

01 Ebrill 2026